logo

For the Inventor, By the Inventor

Beerse, Belgium

Jan Vandenberk

USPTO Granted Patents = 35


Average Co-Inventor Count = 3.3

ph-index = 11

Forward Citations = 513(Granted Patents)


Company Filing History:

goldMedal34 out of 2,077 
 
Janssen Pharmaceutica Nv
 patents
silverMedal1 out of 32 
 
Janssen Pharmaceutica
 patents

Years Active: 1976-2002

Loading Chart...
Loading Chart...
35 patents (USPTO):Explore Patents
1. 6348457 - 4-[3-benzofuranyl]piperidinyl and 4-[3-benzothienyl]piperidinyl derivatives (2002-02-19),
2. 6320048 - 3-piperidinyl-1,2-benzisoxazoles (2001-11-20),
3. 5919788 - 4-(1H-indol-1-yl)-1-piperidinyl derivatives (1999-07-06),
4. 5688799 - 9-Hydroxy-pyrido�1,2-a!pyrimidin-4-one ether derivatives (1997-11-18),
5. 5482943 - (6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl-alkyl-(2, (1996-01-09),
6. 5321028 - Antihypertensive 3-piperidinyl-indazole derivatives (1994-06-14),
7. 5284854 - 2-aminopyrimidinone derivatives (1994-02-08),
8. 5256659 - 2-aminopyrimidinone derivatives (1993-10-26),
9. 5254556 - 3-piperidinyl-1,2-benzisoxazoles (1993-10-19),
10. 5196425 - Antihypertensive 3-piperidinyl-indazole derivatives (1993-03-23),
11. 5158952 - 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 (1992-10-27),
12. 5140029 - 2-aminopyrimidinone derivatives (1992-08-18),
13. 5015740 - Antipsychotic 3-piperazinylbenzazole derivatives (1991-05-14),
14. 4957916 - Antipsychotic 3-piperazinylbenzazole derivatives (1990-09-18),
15. 4804663 - 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles (1989-02-14),

Title: Innovations of Jan Vandenberk in Pharmaceutical Patents

Introduction

Jan Vandenberk, a prominent inventor based in Beerse, Belgium, has made significant contributions to the pharmaceutical industry through his innovative inventions. With a remarkable portfolio of 35 patents, he has established himself as a key figure in the development of new medicinal compounds.

Latest Patents

Among his latest patents, Jan has developed derivatives such as 4-[3-benzofuranyl]piperidinyl and 4-[3-benzothienyl]piperidinyl. Additionally, he has worked on 3-piperidinyl-1,2-benzisoxazoles, which include a disclosed process for preparing an enantiomeric form of the compounds. These latest innovations demonstrate his expertise in creating novel pharmaceutical solutions.

Career Highlights

Jan Vandenberk has had a notable career at Janssen Pharmaceutica NV, a leader in the pharmaceutical field. His work at the company has allowed him to contribute to various groundbreaking projects and expand his knowledge in drug development.

Collaborations

Throughout his career, Jan has collaborated with esteemed colleagues, including Ludo E Kennis and Marcel J Van der Aa. These partnerships have played a vital role in enhancing the research and development processes within the organizations he has been part of.

Conclusion

Jan Vandenberk's extensive portfolio and collaborative efforts in pharmaceutical innovation highlight his vital role in advancing medicine. His latest inventions and ongoing contributions continue to shape the landscape of drug development and provide solutions for various health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…